‘Serious Problem’: EMA Director Criticizes Unpredictable Pharma Submissions

The European Medicines Agency’s executive director said the current practice of companies frequently changing their planned dates for submitting their marketing submission via the centralized procedure was “playing havoc” and was “detrimental to the system.”